Dr Reddy's Laboratories reports 2% rise in Q1 net profit to Rs. 1,418 Cr
Revenue increased 11.4 per cent to Rs. 8,545 crore
Revenue increased 11.4 per cent to Rs. 8,545 crore
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
The FDA set a target action date of April 28, 2026, under the Prescription Drug User Fee Act
Subscribe To Our Newsletter & Stay Updated